申请人:RANBAXY LAB LTD
公开号:WO2012014127A1
公开(公告)日:2012-02-02
The present invention relates to sulfonamides derivatives as 5-lipoxygenase (5-LO) inhibitors and a process for their synthesis. The present invention also relates to pharmacological compositions containing these sulfonamides derivatives, as well as methods of treating bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, multiple sclerosis, Type I diabetes, psoriasis, allograft rejection, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis, allergic rhinitis and other inflammatory and/or autoimmune disorders.
本发明涉及磺胺类衍生物作为5-脂氧合酶(5-LO)抑制剂以及它们的合成方法。本发明还涉及含有这些磺胺类衍生物的药物组合物,以及治疗支气管哮喘、慢性阻塞性肺疾病、类风湿关节炎、多发性硬化症、I型糖尿病、牛皮癣、移植物排斥反应、炎症性肠病、溃疡性结肠炎、痤疮、动脉粥样硬化、癌症、瘙痒症、过敏性鼻炎和其他炎症和/或自身免疫性疾病的方法。